Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2024

Description

Gastroretentive drug delivery systems outsourcing involves pharmaceutical firms engaging external service providers or contract research organizations (CROs) to create and produce drug delivery systems intended to extend the duration of medication within the gastrointestinal (GI) tract. These systems are crafted to boost drug absorption, enhance therapeutic effectiveness, and optimize patient results.

The primary categories of gastroretentive drug delivery systems outsourcing include floating systems, bioadhesive systems, and other variants. A floating drug delivery system (FDDS) is tailored to extend the retention period of medications in the stomach and upper gastrointestinal tract. These systems come in various dosage forms such as tablets, liquids, microspheres, capsules, and others, serving diverse applications such as gastroesophageal reflux disease (GERD), neurological disorders, and more. They are utilized by a range of end-users, including pharmaceutical companies, contract research organizations (CROs), and others.

The gastroretentive drug delivery systems outsourcing market research report is one of a series of new reports from The Business Research Company that provides gastroretentive drug delivery systems outsourcing market statistics, including gastroretentive drug delivery systems outsourcing industry global market size, regional shares, competitors with a gastroretentive drug delivery systems outsourcing market share, detailed gastroretentive drug delivery systems outsourcing market segments, market trends, and opportunities, and any further data you may need to thrive in the gastroretentive drug delivery systems outsourcing industry. This gastroretentive drug delivery systems outsourcing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the rising drug delivery systems, rising prevalence of gastric cancer, rising incidence of stomach and small intestine disorders, rise in government initiatives, and increase in the number of hospitals.

The gastroretentive drug delivery systems outsourcing market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The projected expansion during the forecast period can be credited to the rise in ambulatory centers, the emphasis on enhancing patient compliance and convenience, the surge in chronic diseases, the growth of personalized medicine, and the increasing elderly population. Key trends expected in the forecast period involve progressions in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the innovation of gastroretentive dosage forms, the incorporation of digital health technologies, smart gastroretentive systems, and targeted drug delivery.

The anticipated increase in gastrointestinal disorders is set to drive the expansion of the gastroretentive drug delivery systems outsourcing market in the foreseeable future. Gastrointestinal disorders encompass a broad spectrum of conditions affecting various parts of the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. Factors contributing to the rise in gastrointestinal disorders include aging demographics, the use of antibiotics, exposure to infectious agents, dietary shifts, stress, lifestyle changes, and obesity. Outsourcing the development of gastroretentive drug delivery systems equips pharmaceutical firms with the necessary resources and specialized knowledge to confront the escalating challenge of gastrointestinal disorders, ultimately enhancing patient outcomes and quality of life. For example, the International Foundation for Gastrointestinal Disorders (IFFGD), a nonprofit organization dedicated to education and research, estimates that Irritable Bowel Syndrome (IBS), a prevalent functional gastrointestinal disorder, affects 5-10% of the global population and 25-45 million individuals in the United States alone. IBS alone accounts for 20-40% of gastroenterologist visits, underscoring its substantial impact on individuals and healthcare resources. Hence, the increasing prevalence of gastrointestinal disorders serves as a catalyst for the growth of the gastroretentive drug delivery systems outsourcing market.

Major companies within the gastroretentive drug delivery systems outsourcing market are concentrating on the development of innovative products, such as proton pump inhibitors (PPIs), aimed at improving drug delivery effectiveness and patient convenience. PPIs constitute a category of medications commonly prescribed to address ailments linked to heightened stomach acid levels. For example, in March 2021, Xiromed LLC, a pharmaceutical firm headquartered in the United States, introduced Omeprazole Delayed Release Capsules, 20mg, a generic version of Prilosec. Prilosec (omeprazole) is a proton pump inhibitor utilized in the management of conditions induced by excessive stomach acid production. The formulation of Omeprazole Delayed-Release Capsules provides patients with a consistent and easily identifiable dosage form for omeprazole, thereby facilitating treatment for various gastrointestinal disorders. The distinctive color and coding of the capsules contribute to patient adherence and medication administration accuracy, ensuring optimal dosing and therapeutic effectiveness.

In August 2022, Catalent Inc., a pharmaceutical company headquartered in the United States, completed the acquisition of Metrics Contract Services (Metrics) for an estimated $475 million. Through this strategic move, Catalent intends to fortify its integrated capabilities in oral solid formulation development, manufacturing, and packaging, thereby augmenting its capacity to handle potent compounds and improving its capacity to satisfy customer demands and patient requirements. Metrics Contract Services, based in the United States, is a contract development and manufacturing organization (CDMO) that specializes in providing services for pharmaceutical product development, manufacturing, and analytical testing.

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastroretentive drug delivery systems outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gastroretentive drug delivery systems outsourcing market consists of revenues earned by entities by providing services such as analytical and testing services, formulation development, quality assurance and control, and clinical trial services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroretentive drug delivery systems outsourcing market also includes sales of bioadhesive systems, swelling systems, and high-density systems, and floating systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastroretentive drug delivery systems outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastroretentive drug delivery systems outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastroretentive drug delivery systems outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Floating Systems; Bioadhesive Systems; Other Types
2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications
4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18364

1. Executive Summary

2. Gastroretentive Drug Delivery Systems Outsourcing Market Characteristics

3. Gastroretentive Drug Delivery Systems Outsourcing Market Trends And Strategies

4. Gastroretentive Drug Delivery Systems Outsourcing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Gastroretentive Drug Delivery Systems Outsourcing Market Size and Growth

5.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Gastroretentive Drug Delivery Systems Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Gastroretentive Drug Delivery Systems Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastroretentive Drug Delivery Systems Outsourcing Market Segmentation

6.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Floating Systems
Bioadhesive Systems
Other Types
6.2. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tablets
Liquid
Microspheres
Capsule
Other Dosage Forms
6.3. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Gastroesophageal Reflux Disease (GERD)
Neurological Disorders
Other Applications
6.4. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other End Users

7. Gastroretentive Drug Delivery Systems Outsourcing Market Regional And Country Analysis

7.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market

8.1. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastroretentive Drug Delivery Systems Outsourcing Market

9.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Overview
9.2. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastroretentive Drug Delivery Systems Outsourcing Market

10.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastroretentive Drug Delivery Systems Outsourcing Market

11.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Overview
11.2. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastroretentive Drug Delivery Systems Outsourcing Market

12.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market

13.1. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market

14.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Overview
14.2. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market

15.1. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market Overview
15.2. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastroretentive Drug Delivery Systems Outsourcing Market

16.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastroretentive Drug Delivery Systems Outsourcing Market

17.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastroretentive Drug Delivery Systems Outsourcing Market

18.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastroretentive Drug Delivery Systems Outsourcing Market

19.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastroretentive Drug Delivery Systems Outsourcing Market

20.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market

21.1. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market Overview
21.2. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastroretentive Drug Delivery Systems Outsourcing Market

22.1. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastroretentive Drug Delivery Systems Outsourcing Market

23.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market Overview
23.2. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastroretentive Drug Delivery Systems Outsourcing Market

24.1. USA Gastroretentive Drug Delivery Systems Outsourcing Market Overview
24.2. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastroretentive Drug Delivery Systems Outsourcing Market

25.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Overview
25.2. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastroretentive Drug Delivery Systems Outsourcing Market

26.1. South America Gastroretentive Drug Delivery Systems Outsourcing Market Overview
26.2. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market

27.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market

28.1. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market Overview
28.2. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastroretentive Drug Delivery Systems Outsourcing Market

29.1. Africa Gastroretentive Drug Delivery Systems Outsourcing Market Overview
29.2. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Landscape And Company Profiles

30.1. Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Landscape
30.2. Gastroretentive Drug Delivery Systems Outsourcing Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sanofi S.A.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Gastroretentive Drug Delivery Systems Outsourcing Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GlaxoSmithKline plc
31.4. Evonik Industries AG
31.5. Alcon Inc.
31.6. SGS SA
31.7. Lonza Group AG
31.8. FMC Corporation
31.9. Sun Pharmaceutical Industries Ltd.
31.10. Catalent Inc.
31.11. AptarGroup Inc.
31.12. Cadila Pharmaceuticals
31.13. Ashland Global Holdings Inc
31.14. Lupin Limited
31.15. Torrent Pharmaceuticals Ltd.

32. Global Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Benchmarking

33. Global Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gastroretentive Drug Delivery Systems Outsourcing Market

35. Gastroretentive Drug Delivery Systems Outsourcing Market Future Outlook and Potential Analysis

35.1 Gastroretentive Drug Delivery Systems Outsourcing Market In 2028 - Countries Offering Most New Opportunities
35.2 Gastroretentive Drug Delivery Systems Outsourcing Market In 2028 - Segments Offering Most New Opportunities
35.3 Gastroretentive Drug Delivery Systems Outsourcing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer